本文选自Chinadaily，原文链接见Govt brings 17 anti-cancer drugs under medical insurance coverage。
China's drug authority（药监局） on Wednesday approved inclusion（包括） of 17 anti-cancer drugs in the government's basic medical insurance programs, as part of efforts to ease（减轻） the financial burden on patients.
Starting from June, the State Administration of Medical Insurance has been in negotiations with（协商） domestic and overseas pharmaceutical companies, with the aim to lower the prices and put more anti-cancer drugs under medical insurance.
The 17 patented drugs include 12 for solid tumors（固体肿瘤） treatment and the other five for hematological neoplasms（血液肿瘤） treatment, which all have curative（治疗效果） effort for clinical trial（临床试验）. And after inclusion in medical insurance, the average price fall was 56.7 percent, compared to the retail prices.
The country lifted the import tariffs（免除进口关税） on 103 of 138 anti-cancer drugs available in May, and significantly reduced the value added tax levied（征收） on these drugs. On the list of 103 anti-cancer drugs, 82 types have been included in the governments' basic medical insurance programs.
